Nocardia veterana bloodstream infection in a patient with cancer and a summary of reported cases  by Ansari, Shoaib R. et al.
Letters to the Editor 483In conclusion, this is the first reported case of an infection
caused by MRSA carrying the Panton—Valentine leukocidin
(PVL) gene in Shanghai, China. The emergence of such strains
in Shanghai, a densely populated city with a high incidence of
MRSA, indicates the necessity of epidemiological surveillance
of these clinically important strains.
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doi:10.1016/j.ijid.2006.06.002Nocardia veterana bloodstream infection in a
patient with cancer and a summary of reported
cases
Nocardia species are aerobic nocardioform actinomycetes
associated most commonly with pulmonary and central ner-
vous system infections in patients with cellular immune
defects.1—3 Nocardia bloodstream infections, however, are
seldom seen even in severely immunosuppressed patients
with an underlying malignancy.4,5 Most systemic infections
are due to Nocardia asteroides complex including N. aster-
oides sensu stricto, Nocardia farcinica, and Nocardia nova. In
recent years, molecular methods that rely on 16S rRNA gene
sequencing have resulted in the reclassification of some
actinomycetes and in the identification of previously
unknown species.6—8 Nocardia veterana is among these newly
identified species.9 N. veterana has been reported to cause
pneumonia, ascites, and mycetoma; however, bloodstream
infection with N. veterana has not been described.9—13We present herein the case of a cancer patient with N.
veterana bacteremia complicating a pulmonary infection.
We also review the published cases of N. veterana infections
in humans.
A 58-year-old man with chronic lymphocytic leukemia and
non-small cell lung carcinoma of the right lung presented
with a five-day history of fever, dyspnea, right lower chest
pain, and a productive cough that exacerbated the pain. The
patient had recently received fludarabine, cyclophospha-
mide, and rituximab for relapsed leukemia; treatment for
the lung cancer had not been started. Three months prior
to this presentation, the patient was given prednisone
(20 mg/day) for refractory autoimmune hemolytic anemia
and thrombocytopenia. In the month preceding this presen-
tation, the patient had been hospitalized for possible fungal
pneumonia.
On chest auscultation at presentation, decreased
breath sounds were noted in the upper right lung and were
accompanied by coarse sounds throughout the lung; a
grade 2/6 mid-systolic heart murmur was also audible.
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Figure 1 Non-contrast-enhanced chest computed tomography
scan showing loculated pleural effusion and compression atelec-
tasis (arrowhead) in right lung; multiple non-cavitary pulmonary
nodules are evident in the left upper lung lobe (arrow).
Table 1 Summary of published cases of Nocardia veterana infec
Reference Age
and sex
Underlying disease
and concurrent
infections
Systemic
corticoste
usea
Gurtler et al. 9 70 y, male NA NA
Kano et al. 10 45 y, female SLE Yes
Pottumarthy
et al. 11
47 y, male Orthotopic liver
transplantation
for HCV, concurrent
HCMV
Yes
43 y, female SLE Yes
67 y, female Bronchiectasis No
Conville et al. 12 24 y, male X-linked chronic
granulomatous
disease
No
63 y, male Single lung transplant
for COPD, acute graft
rejection, invasive
Aspergillus fumigatus
native lung infection
Yes
Godreuil et al. 13 40 y, male Advanced body cavity
lymphoma, AIDS,
chronic HBV infection
Yes
NA, not available; BAL, bronchoalveolar lavage; SLE, systemic lupus
disease; HCMV, human cytomegalovirus; TMP—SMX, trimethoprim—sulfa
fine-needle aspiration; AIDS, acquired immunodeficiency syndrome;
improved or recurred after antimicrobial therapy was discontinued.
a Systemic corticosteroids, prednisone equivalent dose of >10 mg daThe laboratory studies showed the following: white blood
cell count, 34.6  109 cells/L; absolute neutrophil count,
1.04  109 cells/L; hemoglobin, 13 g/dL; fasting glucose,
271 mg/dL; total bilirubin, 1.2 mg/dL; alkaline phospha-
tase, 111 U/dL; lactate dehydrogenase, 495 U/dL; and
alanine aminotransferase, 21 U/dL. Chest computed tomo-
graphy showed no change in the size of the perihilar cancer
in the right lung; a loculated pleural effusion and compres-
sion atelectasis in the right lung were new, and so were
multiple nodular opacities in the left upper lung lobe
(Figure 1). An echocardiogram showed moderate stenosis
of the aortic valve.
Branching Gram-positive bacteria grew in a peripheral-
blood culture specimen using Bactec 9240 automated cultur-
ing system in Aerobic/F bottle with resin (BD Diagnostic
System, Sparks, MD, USA). The cultures became positive
after incubation for six days, the organisms were weakly
acid-fast positive, and N. veteranawas identified by 16S rRNA
gene sequencing.7 Nocardia veterana and N. nova were
isolated from bronchoalveolar lavage and bronchial washing
samples; Aspergillus fumigatus also grew in a bronchial
washing sample. Cytomegalovirus (CMV) antigens were
detected in the same bronchial fluid. A left lung biopsy
showed numerous fungal hyphae on Grocott—Gomori methe-
namine—silver nitrate staining, and a culture from thetion
roid
N. veterana
infection site
Culture
samples
Treatment Infection
outcome
Lung BAL NA NA
Mycetoma Tissue biopsy Ampicillin,
sulfonamides,
surgery
Improved
Lung Lung biopsy TMP—SMX Resolved
Lung BAL TMP—SMX Resolved
Lung Sputum Minocycline,
amoxicillin,
azithromycin
Improved
Lung Lung biopsy Ceftriaxone,
amikacin, TMP
Improved
Lung FNA TMP—SMX Improved
Acute
peritonitis
Peritoneal
fluid
None Died
erythematosus; HCV, hepatitis C virus-associated end stage liver
methoxazole; COPD, chronic obstructive pulmonary disease; FNA,
HBV, hepatitis B virus. ‘Improved’ was either infection partially
ily.
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Table 2 Susceptibility profile of Nocardia veterana isolated from patients with documented infection
Antimicrobial Resistance (MIC) Case 1 Case 2 Case 3 Case 4 Case 5 Case 6 Case 7
Amikacin 16 <2 0.25 0.25 S <0.25 <0.25 0.5
Amoxicillin—clavulanic acid 32/16 16/32 16 16 S 16/8 16/8 32/16
Ampicillin 32 2 2 0.5 S 2 4 NA
Ceftriaxone 64 8—16 >32 >32 NA 8 8 8
Ciprofloxacin 4 8 >32 >32 NA 4 8 8
Clarithromycin 8 NA NA NA NA <0.25 <0.25 0.25
Imipenem 6 <0.5 0.032 0.064 S <0.25 <0.25 1
Linezolid NA NA NA NA NA 2 2 NA
Minocycline 8 2—4 4 4 NA 2 2 2
Sulfamethoxazole 64 NA NA NA NA 64 64 NA
Trimethoprim—sulfamethoxazole 4/76 0.5/9.5 0.25/4.7 0.25/4.7 S 1/19 1/19 0.5/9.5
Vancomycin NA NA NA R >32 >32 NA
MIC, minimum inhibitory concentration in mg/mL; NA, not available; S, susceptible; R. resistant. Cases 1 to 3, Pottumarthy et al.;11 case 4,
Godreuil et al.;13 cases 5 and 6, Conville et al.;12 case 7, current case.specimen grew N. veterana and N. nova. A serum galacto-
mannan assay revealed a fungal antigen of >1 ng/mL (Pla-
telia Aspergillus EIA, Bio-rad, Marnes-la-Coquette, France).
The patient received intravenous trimethoprim—
sulfamethoxazole (10 mg/kg in three divided doses daily)
plus voriconazole (6 mg/kg two doses, then 4 mg/kg
twice daily), azithromycin (500 mg daily), piperacillin/tazo-
bactam (3.375 g every 6 h), and oral valganciclovir (900 mg
twice daily). Complete resolution of the pulmonary infection
was noted three weeks after antimicrobial therapy com-
menced. All follow-up respiratory tract samples and blood
cultures remained sterile for Nocardia species.
Nocardia veterana, similar to other species of Nocardia
asteroides complex, may lead to a variety of infections; the
cases reported to date are summarized in Table 1. The most
commonly reported site of N. veterana infection is the lungs.
The case presented here is, to our knowledge, the first
reported case of N. veterana bloodstream infection. In this
case the bloodstream infection was probably related to the
pulmonary infection rather than to an infected indwelling
intravascular catheter.4,5
It was unexpected to find two different Nocardia species
co-existing with invasive pulmonary aspergillosis (IPA) in the
same lesion. The patient also had active CMV replication in
the lower respiratory tract; this may have further increased
the risk of opportunistic infections.11,14 Concomitant pul-
monary CMV and Nocardia species infections have mostly
been observed in recipients of allogeneic stem cell or organ
transplants.11,15 In our patient, the important predisposing
risk factors for systemic nocardiosis, IPA, and probable CMV
reactivation were recent treatment with fludarabine and
prolonged (more than four weeks) systemic corticosteroid
therapy.1,16 In the absence of known risk factors for systemic
nocardiosis, isolation of Nocardia species known to be patho-
genic in humans should be interpreted with caution. In
patients who do not have known risk for systemic nocardiosis,
including cancer patients without cellular immune dysfunc-
tion and/or systemic corticosteroid use, the presence
of Nocardia species in respiratory samples may represent
colonization or subclinical infection that often resolves
spontaneously.17,18
N. veterana is phenotypically indistinguishable from N.
nova, and despite genetic differences, the antimicrobialsusceptibility profile for these two Nocardia species is nearly
identical.19 N. veterana, similar to N. nova, is relatively
resistant in vitro to amoxicillin—clavulanic acid (Table 2),
whereas most Nocardia isolates show susceptibility to amox-
icillin alone. Wallace et al. proposed the following
mechanism of resistance: clavulanic acid induces mem-
brane-bound b-lactamase, which may in turn compromise
the antimicrobial activity of amoxicillin; whereas amoxicillin
when used in the absence of clavulanic acid retains anti-
Nocardia activity.11,19 Trimethoprim—sulfamethoxazole is
the drug of choice for Nocardia infections, at doses of
10 mg/kg to 15 mg/kg daily. In seven of eight cases of N.
veterana infection, including the case presented here, in
whom known appropriate antimicrobial therapy was given,
treatment was associated with a favorable response despite
the presence of concurrent IPA and HCMV infection in some
cases (Table 1).
In conclusion, 16S rRNA gene sequencing is an invaluable
tool in correctly identifying the new emerging Nocardia
species. N. veterana can lead to serious systemic infection
in cancer patients receiving systemic corticosteroids and
may accompany other opportunistic infections such as IPA
and CMV. A high index of suspicion is critical in making the
correct diagnosis in at-risk patients and promptly instituting
appropriate therapy for systemic nocardiosis.
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doi:10.1016/j.ijid.2006.03.005Evaluation of thin needle aspiration biopsy in
the diagnosis and management of vertebral
osteomyelitis (VO)
Vertebral osteomyelitis (VO) is associated with serious mor-
bidity and mortality. Needle aspiration biopsy is generally
necessary to confirm the clinical and/or radiographic suspi-
cion of VO. This study was conducted to assess the usefulness
of thin needle aspiration biopsy in confirming the diagnosis
and identifying the etiologic agent of VO.
A retrospective chart review was conducted at a metro-
politan teaching hospital in New York, USA. Patients were
identified by discharge diagnosis and from records in the
radiology department of patients who underwent needle
bone biopsy. Patients with sacral osteomyelitis and history
of vertebral surgery were excluded.
Charts of 25 patients were reviewed. Fifty-six percent of
patients were over 65 years of age, 60% were male, and 68%
were Caucasian. Back pain was present in 92%, fever in 55%,
and both symptoms in 44%. Mean duration of presentingsymptoms prior to diagnosis was 63 days. Mean WBC count
was 10.6  109/L and ESR was >100 mm/h in 64%. Bacter-
emia was present in 11 patients. The most common site of
infection was L2—3. Thoracic vertebrae were involved in 24%
and cervical vertebrae in 8%. Needle aspiration was per-
formed in 17 patients. Pathology and/or culture were posi-
tive for VO in 11 patients. Both were positive in three
patients. Pathology was consistent with VO in five and culture
was positive in nine. In 13 patients with lumbar VO who
underwent needle aspiration, 10 biopsies were positive.
Seventy percent had associated epidural abscess. In four
patients with thoracic VO undergoing needle aspiration, only
25% were positive. Organisms isolated from aspirate were
Staphylococcus aureus (3), group B streptococci (1), Escher-
ichia coli (1),Mycobacterium tuberculosis (1), and coagulase
negative staphylococci (3). Results of needle biopsy and
blood culture correlated in only three patients. Ten patients
received antibiotics prior to admission, 70% of whom had
negative aspirate cultures. Patients who underwent needle
biopsy experienced shorter hospital stays, although this
result was statistically insignificant.
